Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Beckman Coulter Use InterSystems Ensemble Integration Platform

Published: Monday, December 17, 2012
Last Updated: Monday, December 17, 2012
Bookmark and Share
New solution eliminates manual booking of laboratory samples.

InterSystems has announced that Beckman Coulter is using InterSystems Ensemble® to improve the way samples are processed in hospital laboratories around the UK.

Ensemble is a platform for the rapid integration and development of connectable applications.

The new Automated Sample Receipting (ASR) solution was developed in less than six months and enables an end-to-end pathology service that is significantly more streamlined than current manual processes.

Early in 2012, in the pursuit of the highest quality balanced with cost efficiency in laboratory services, Beckman Coulter decided to create functionality within one of its sample processing systems that would eliminate the manual booking of samples.

Following a review of several options including using its own technology, Beckman Coulter chose Ensemble to integrate the target data management systems with hospital laboratory information systems and order communications systems.

As a result, samples can now be automatically recorded rather than requiring staff to scan individual sample barcodes manually.

Leanne Annereau, Marketing Manager at Beckman Coulter, said, “We are delighted to have partnered with InterSystems. We have been impressed by their collaborative approach, and the speed at which Ensemble enabled us to complete our product development - in less than six months from concept to delivery. From the start, we felt InterSystems had the right product and experience to make the project a success. We are now looking at other ways we can work together.”

The ASR solution service provides a number of distinct benefits to hospitals and clinicians. By reducing labour-intensive steps within laboratory processes, Beckman Coulter estimate a single laboratory can now process about 3,000 tubes daily, which translates into significant time and cost savings over manual processes.

In addition, the solution will improve the quality of results, since a significant proportion of pathology errors are related to the mishandling of samples or mismatching of patient information.

Jonathan Selby, Country Manager UK & Ireland at InterSystems, said, “We have built a strong partnership in a short time, and we are excited by the prospect of continuing our work supporting Beckman Coulter in their development of breakthrough solutions that simplify processes, improve accuracy, and reduce costs in biomedical testing.”

Beckman Coulter estimates that the first pilot sites will be operational before the end of the year.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Autism and Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Number Of Known Genetic Risk Factors For Endometrial Cancer Doubled
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!